Literature DB >> 32054728

Impact of e-cigarette use among a cohort of American Indian cigarette smokers: associations with cigarette smoking cessation and cigarette consumption.

Ashley L Comiford1, Dorothy A Rhoades2, Paul Spicer3, Justin D Dvorak4, Kai Ding4, Theodore L Wagener5,6, Mark P Doescher2.   

Abstract

INTRODUCTION: Despite American Indian/Alaska Native (AI/AN) people having the highest prevalence of cigarette smoking nationwide, few studies have evaluated e-cigarette use among AI/AN adults who smoke. The primary objective of this observational pilot cohort study was to determine if e-cigarette use is associated with cigarette smoking cessation or reduction among adult AI individuals who smoke.
METHODS: In 2016, we collected baseline survey and biomarker data among AI adults who smoke. The survey included questions about cigarette consumption and use of e-cigarettes and biomarkers, such as salivary cotinine markers and exhaled carbon monoxide. After 18 months, we repeated data collection, and asked about changes in cigarette smoking status and cigarettes per day (CPD). Comparisons between groups were performed using the χ2 test, Fisher's exact test or Wilcoxon rank-sum test.
RESULTS: Of 375 baseline participants, 214 (57.07%) returned for follow-up and were included in analyses. Of these, 20 (9.3%) reported having stopped cigarette smoking and had biochemical verification of cigarette smoking abstinence. Among those who quit smoking, 15% were baseline e-cigarette users; while among those who continued to smoke at follow-up, about 11% were baseline e-cigarette users. This difference was not statistically significant (p=0.48). Among all those who continued to smoke at follow-up, there was no overall decrease in CPD, nor a significant difference in change in CPD between baseline e-cigarette users and non-users (p=0.98).
CONCLUSIONS: E-cigarette use at baseline was not associated with smoking cessation or a change in CPD in this cohort of AI adults who smoke after an 18-month follow-up period. © Author(s) (or their employer(s)) 2021. No commercial re-use. See rights and permissions. Published by BMJ.

Entities:  

Keywords:  cessation; disparities; electronic nicotine delivery devices

Mesh:

Year:  2020        PMID: 32054728      PMCID: PMC8132298          DOI: 10.1136/tobaccocontrol-2019-055338

Source DB:  PubMed          Journal:  Tob Control        ISSN: 0964-4563            Impact factor:   7.552


  35 in total

1.  Evaluation of toxicant and carcinogen metabolites in the urine of e-cigarette users versus cigarette smokers.

Authors:  Stephen S Hecht; Steven G Carmella; Delshanee Kotandeniya; Makenzie E Pillsbury; Menglan Chen; Benjamin W S Ransom; Rachel Isaksson Vogel; Elizabeth Thompson; Sharon E Murphy; Dorothy K Hatsukami
Journal:  Nicotine Tob Res       Date:  2014-10-21       Impact factor: 4.244

2.  Cohort study of electronic cigarette use: safety and effectiveness after 4 years of follow-up.

Authors:  M E Flacco; M Ferrante; M Fiore; C Marzuillo; C La Vecchia; M R Gualano; G Liguori; G Fragassi; T Carradori; F Bravi; R Siliquini; W Ricciardi; P Villari; L Manzoli
Journal:  Eur Rev Med Pharmacol Sci       Date:  2019-01       Impact factor: 3.507

3.  Leading causes of death and all-cause mortality in American Indians and Alaska Natives.

Authors:  David K Espey; Melissa A Jim; Nathaniel Cobb; Michael Bartholomew; Tom Becker; Don Haverkamp; Marcus Plescia
Journal:  Am J Public Health       Date:  2014-04-22       Impact factor: 9.308

4.  Racial/ethnic differences in menthol cigarette smoking, population quit ratios and utilization of evidence-based tobacco cessation treatments.

Authors:  Mandy Stahre; Kolawole S Okuyemi; Anne M Joseph; Steven S Fu
Journal:  Addiction       Date:  2010-12       Impact factor: 6.526

5.  Reasons for current E-cigarette use among U.S. adults.

Authors:  Deesha Patel; Kevin C Davis; Shanna Cox; Brian Bradfield; Brian A King; Paul Shafer; Ralph Caraballo; Rebecca Bunnell
Journal:  Prev Med       Date:  2016-09-07       Impact factor: 4.018

6.  Quit interest, quit attempt and recent cigarette smoking cessation in the US working population, 2010.

Authors:  Lee C Yong; Sara E Luckhaupt; Jia Li; Geoffrey M Calvert
Journal:  Occup Environ Med       Date:  2014-02-04       Impact factor: 4.402

7.  Electronic Cigarette Use Among Adults: United States, 2014.

Authors:  Charlotte A Schoenborn; Renee M Gindi
Journal:  NCHS Data Brief       Date:  2015-10

8.  Views on electronic cigarette use in tobacco screening and cessation in an Alaska Native healthcare setting.

Authors:  Vanessa Y Hiratsuka; Jaedon P Avey; Susan B Trinidad; Julie A Beans; Renee F Robinson
Journal:  Int J Circumpolar Health       Date:  2015-10-19       Impact factor: 1.228

9.  Smoking cessation and attempted cessation among adults in the United States.

Authors:  Amir Goren; Kathy Annunziata; Robert A Schnoll; Jose A Suaya
Journal:  PLoS One       Date:  2014-03-27       Impact factor: 3.240

10.  Cohort study of electronic cigarette use: effectiveness and safety at 24 months.

Authors:  Lamberto Manzoli; Maria Elena Flacco; Margherita Ferrante; Carlo La Vecchia; Roberta Siliquini; Walter Ricciardi; Carolina Marzuillo; Paolo Villari; Maria Fiore
Journal:  Tob Control       Date:  2016-06-06       Impact factor: 7.552

View more
  3 in total

1.  Investigating the effect of e-cigarette use on quitting smoking in adults aged 25 years or more using the PATH study.

Authors:  Peter N Lee; John S Fry
Journal:  F1000Res       Date:  2020-09-07

2.  Use of Electronic Nicotine Delivery Systems (ENDS) in China: Evidence from Citywide Representative Surveys from Five Chinese Cities in 2018.

Authors:  Jidong Huang; Zongshuan Duan; Yu Wang; Pamela B Redmon; Michael P Eriksen
Journal:  Int J Environ Res Public Health       Date:  2020-04-08       Impact factor: 3.390

3.  Estimating the reduction in US mortality if cigarettes were largely replaced by e-cigarettes.

Authors:  Peter N Lee; John S Fry; Stanley Gilliland; Preston Campbell; Andrew R Joyce
Journal:  Arch Toxicol       Date:  2021-10-22       Impact factor: 5.153

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.